Minor histocompatibility antigens: past, present, and future

Area of Science:

• Immunology
• Transplantation Science
• Genetics

Background:

• Minor histocompatibility (H) antigens are crucial in immune responses following transplantation, influencing both graft-versus-host disease (GvHD) and graft-versus-leukemia (GvL) reactivity.
• Their distinct tissue expression patterns (hematopoietic-restricted vs. broad) dictate their immunomodulatory roles.

Purpose of the Study:

• To elucidate the immunogenetics of minor H antigens.
• To review methods for identifying minor H antigens.
• To summarize the clinical significance of minor H antigens in hematopoietic stem-cell transplantation (HSCT) and solid-organ transplantation.

Main Methods:

• Review of immunogenetic principles governing minor H antigen recognition.
• Description of techniques utilized for minor H antigen discovery.
• Synthesis of clinical data from HSCT and solid-organ transplant studies.

Main Results:

• Minor H antigens exhibit dual roles in GvHD and GvL, dependent on their expression profiles.
• Hematopoietic system-restricted minor H antigens are particularly promising for GvL immunotherapy.
• Broadly expressed minor H antigens contribute to both beneficial GvL and detrimental GvHD.

Conclusions:

• Targeting minor H antigens offers a strategy to enhance GvL responses for treating hematological malignancies.
• Understanding minor H antigen immunogenetics is vital for optimizing transplant outcomes.
• Clinical application of minor H antigen knowledge spans HSCT and solid-organ transplantation.